Enlivex Therapeutics Ltd (ENLV)
0.9900 x 20 1.0400 x 11
Post-market by (Cboe BZX)
1.0300 +0.0500 (+5.10%) 04/28/25 [NASDAQ]
0.9900 x 20 1.0400 x 11
Post-market 1.0300 unch (unch) 15:58 ET
for Mon, Apr 28th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -15,014 | -29,068 | -31,060 | -14,468 | -11,824 |
| Depreciation Amortization | 545 | 835 | 777 | 546 | 286 |
| Accounts receivable | 433 | N/A | N/A | -1,249 | 1,823 |
| Accounts payable and accrued liabilities | -16 | -1,121 | 1,168 | 442 | 36 |
| Other Working Capital | -1,218 | -1,818 | 804 | -1,357 | -306 |
| Other Operating Activity | 2,262 | 7,649 | 4,358 | -1,456 | -1,022 |
| Operating Cash Flow | $-13,008 | $-23,523 | $-23,953 | $-17,542 | $-11,007 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 6,869 | -25,865 | 70,646 | -36,783 | -19,958 |
| PPE Investments | 81 | -103 | -8,122 | -1,625 | -1,019 |
| Other Investing Activity | 2,109 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $9,059 | $-25,968 | $62,524 | $-38,408 | $-20,977 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 6,454 | 360 | 150 | 60,982 | 33,082 |
| Financing Cash Flow | $6,454 | $360 | $150 | $60,982 | $33,082 |
| Exchange Rate Effect | N/A | N/A | N/A | -408 | 390 |
| Beginning Cash Position | 1,226 | 50,357 | 11,636 | 7,012 | 5,524 |
| End Cash Position | 3,731 | 1,226 | 50,357 | 11,636 | 7,012 |
| Net Cash Flow | $2,505 | $-49,131 | $38,721 | $4,624 | $1,488 |
| Free Cash Flow | |||||
| Operating Cash Flow | -13,008 | -23,523 | -23,953 | -17,542 | -11,007 |
| Capital Expenditure | -103 | -236 | -8,122 | -1,625 | -1,019 |
| Free Cash Flow | -13,111 | -23,759 | -32,075 | -19,167 | -12,026 |